Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: DELT1970 who wrote (9800)	7/21/1998 1:56:00 PM
From: Ron Luhmann	Respond to of 14328

I expect Unigold HIV FDA before year's end... earnings due any day now....the Strep A is a big market...this is only FDA submission...but when Unigold gets thru the others will not take as long..same technology notice the reference to 5 min doctor's office turn around..I hope the HMO's are watching...Point of Care (POC)is on the GO...now GO TRIBY ! late press release not like TRIBY but they don't control when info is released to public.... GOOD NEWS regardless!

To: DELT1970 who wrote (9800)	7/21/1998 2:11:00 PM
From: Decci	Respond to of 14328

Grobnette, Thanks!!! I am watching and I still hold my my core position + some warrants. I am more confident about the future. We will realize price growth soon as Newla, in Dublin, has officially said that TRIBY expects UniGold HIV approval this year. Technology validation and increased earnings are the keystones of this company right now. I also expect a mild earnings surprise of a solid .0275 to .03 ( EST $700,000 Q profit) as opposed to an iffy .02. I believe management has an agenda that we must trust. In the past 2 years we have seen improved earnings, even with the increased number of shares. I am sure the company is sensitive to dilution and will be self-restrained before issuing more shares. A carrot to the warrant holders will not have significant impact on the total number of shares; I think not more than 1.3 million shares that is if the share price gets to $3. JMO OUT